Clear Street’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Clear Street’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273	Buy	6,228 +200	+3%	+$19	﹤0.01%	1067
2025 Q4	$726	Sell	6,028 -100	-2%	-$16	﹤0.01%	878
2025 Q3	$735	Hold	6,128	–	–	﹤0.01%	782
2025 Q2	$314	Sell	6,128 -500	-8%	-$32	﹤0.01%	631
2025 Q1	$180	Buy	6,628 +5,000	+307%	+$130	﹤0.01%	530
2024 Q4	$8	Sell	1,628 -265	-14%	-$4	﹤0.01%	575
2024 Q3	$38	Sell	1,893 -500	-21%	-$10	﹤0.01%	675
2024 Q2	$63	Buy	2,393 +800	+50%	+$62	﹤0.01%	748
2024 Q1	$319	Hold	1,593	–	–	﹤0.01%	702
2023 Q4	$319	Buy	1,593 +500	+46%	+$79	﹤0.01%	717
2023 Q3	$100	Buy	1,093 +700	+178%	+$57	﹤0.01%	1027
2023 Q2	$11	Buy	393 +200	+104%	+$11	﹤0.01%	1278
2023 Q1	$13	Buy	+193	New	+$24	﹤0.01%	1155

Other funds holding STLNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Clear Street's STLNW Position: Q1 2026 in Review

Clear Street increased its Starling Oncology, Inc. Warrant (STLNW) stake by 3.3% in Q1 2026, buying an estimated $19 and bringing the position to 6,228 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Clear Street first reported a position in STLNW in Q1 2023 and has held it in 13 quarters since. The position peaked at $735 in Q3 2025. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.

Clear Street held 6,228 shares of Starling Oncology, Inc. Warrant worth $273 as of Q1 2026.
Clear Street bought 200 Starling Oncology, Inc. Warrant shares in Q1 2026, an estimated $19.
Starling Oncology, Inc. Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1067 holding.
Clear Street first reported a position in Starling Oncology, Inc. Warrant in Q1 2023 and has held it in 13 quarters since.
Clear Street's Starling Oncology, Inc. Warrant position peaked at $735 in Q3 2025.
11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.